Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series
Jonathan A. Leighton, Chieh Grace Lau, Aisha Savdo, L Granata
Cephalalgia Reports May 1, 2025 DOI: 10.1177/25158163251345472 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case series Case report Peer reviewed |
|---|---|
| Sample size | 9 |
| Population | Patients with episodic or chronic cluster headache that did not respond to conventional treatments |
| Interventions | Psilocybin LSD Ketamine |
| Topics | Ketamine LSD Psilocybin Serotonin Esketamine |
| Keywords | Hallucinogen Cluster headache |
| Citations | 2 |
| Key findings | Eight of nine patients with treatment-resistant cluster headache responded positively to psilocybin or LSD, with several experiencing extended attack-free periods. |
Abstract
Background: Cluster headache is an excruciating condition for which standard treatments are usually insufficient. Evidence has accumulated that serotonergic psychedelic indoleamines including psilocybin and LSD can be effective in preventing attacks.
Methods: In this case series, nine patients with episodic and chronic cluster headache that didn’t respond to conventional treatments were treated at a clinic with psilocybin or LSD, under compassionate use provisions, and in most cases separately with ketamine.
Results: All patients responded positively to at least one of the treatments, and eight of nine responded positively to the treatment with the psychedelic indoleamines, in several cases with extended periods free of attacks.
Conclusion: These clinical data, though of an exploratory nature, add to the existing pool of evidence for the usefulness of these substances for treating cluster headache, and further support the lowering of legal and regulatory barriers to medical access to the psychedelic indoleamines.
Comparable studies
Other case reports and case series on LSD, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Lasting Neuropsychiatric Sequelae of (??)Methylenedioxymethamphetamine (???Ecstasy???) in Recreational Users Persons who ingested large doses of MDMA | 1991 | Case study | n = 2 |
| Further Studies in the Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness Patients with mental illness | 1957 | Case series | |
| Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose a Report of Eight Cases People who self-administered large amounts of pure LSD powder intranasally | 1975 | Case series | n = 8 |
| Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders Patients with chronic complex post-traumatic stress disorder (c-PTSD), dissociative,... | 2022 | Case series | |
| Persistent Palinopsia Following Ingestion of Lysergic Acid Diethylamide (LSD) Patients who developed persistent palinopsia after LSD ingestion | 1996 | Case series | n = 3 |
Citations in the library
Cites 3
- Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey Journal of Psychoactive Drugs October 20, 2015
- Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial. Journal of the Neurological Sciences May 15, 2024
- CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity Headache: The Journal of Head and Face Pain 2024